Net income: US$6.02b (down 20% from FY 2023). Profit margin: 9.6% (down from 12% in FY 2023). EPS: US$6.53 (down from US$8.25 in FY 2023). Revenue was in line with analyst estimates. Earnings per ...

NBC Justice reporter Ryan Reilly and former U.S. Attorney Harry Litman join Nicolle Wallace to react to the breaking news that the office of acting deputy attorney general Emil Bove has asked the ...

Lifehacker has been a go-to source of tech help and life advice since 2005. Our mission is to offer reliable tech help and credible, practical, science-based life advice to help you live better ...

Net income: US$6.02b (down 20% from FY 2023). Profit margin: 9.6% (down from 12% in FY 2023). EPS: US$6.53 (down from US$8.25 in FY 2023). Revenue was in line with analyst estimates. Earnings per ...

Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025 Paris, January 30, 2025 Q4: sales growth of 10.3% at CER 1 and business EPS ...

(RTTNews) - Dover (DOV) said, in 2025, it expects to generate GAAP EPS from continuing operations in the range of $8.16 to $8.36. Adjusted EPS from continuing operations is projected in a range of ...

Pharma launches up 56.5%, reaching sales of €0.8 billion, 8% of total sales, led by ALTUVIIIO Dupixent sales up 16.0% to €3.5 billion Vaccines sales up 10.8% to €2.2 billion, driven by Beyfortus sales ...

6 Applying average January 2025 exchange rates, the currency impacts are estimated between +2% and +3% on sales and +2% and +3% on business EPS. 7 At CER. 8 Free cash flow is a non-IFRS financial ...

Sanofi confirms the expectation of a strong rebound in business EPS with growth at a low double-digit percentage at CER (before share buyback).6 Sanofi intends to execute a share buyback program ...

Piper Sandler analyst Andrew Liesch lowered the firm’s price target on West Bancorporation (WTBA) to $23 from $25 and keeps a Neutral rating on ...